Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
08/1999
08/11/1999CN1225362A Indole derivatives
08/10/1999US5936127 Asymmetric synthesis and catalysis with chiral heterocyclic compounds
08/10/1999US5936099 N-alkyl phthalamides by reacting liquid (c3-c6)alkylamines and phthalic anhydride; nitration followed by reacting with a bisphenol a; exchange reaction to form dianhydride; hydrolysis to produce tetracid monomer for polyetherimides
08/10/1999US5936098 Process for producing indoline compounds and intermediates for the production of the same
08/10/1999US5936097 Antitumor agents
08/10/1999US5936089 Dipeptides which promote release of growth hormone
08/10/1999US5936087 Dibenzorhodamine dyes
08/10/1999US5935976 Viricides, hiv
08/10/1999US5935960 Treatment of schizophrenia
08/10/1999US5935907 Phenylacetylene derivatives
08/05/1999WO1999039203A1 Energy transfer dyes
08/05/1999WO1999038820A1 The use of compressed co2 in chemical reactions
08/05/1999WO1999000128A9 Antithrombotic agents
08/05/1999DE19804251A1 Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Biphenylsulfonylcyanamide, processes for their preparation and their use as a medicament
08/05/1999DE19804085A1 New benzo-condensed heterocyclic compounds useful in treatment of thrombosis and prevention of vascular occlusion
08/05/1999CA2319490A1 Energy transfer dyes
08/04/1999EP0933354A1 Calcium receptor-active compounds
08/04/1999EP0933351A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0933350A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0932658A2 Asymmetrical imide bleach activators and compositions employing the same
08/04/1999EP0932598A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
08/04/1999EP0932406A1 Methods of treating or preventing interstitial cystitis
08/04/1999EP0752985B1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
08/04/1999EP0575490B1 GnRH ANALOGS
08/04/1999CN1225083A Calcium receptor-active compounds
08/04/1999CN1225009A Pentafluorobenzenesulfonamides and analogs
08/04/1999CN1224720A Tetracylic derivatives, process of preparation and use
08/04/1999CN1224715A Cycloalkano-indote and againdole derivatives, process for their preparation and pharmaceutical composition containing the same
08/04/1999CN1224714A N-(4-carbamimido-phenyl)-phenylglycinamid derivatives
08/03/1999US5932765 Nitromethyl ketones, process for preparing them and compositions containing them
08/03/1999US5932744 Process for the preparation of cis-hexahydroisoindoline derivatives
08/03/1999US5932743 Methods for the solid phase synthesis of substituted indole compounds
08/03/1999US5932732 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
08/03/1999US5932729 1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands
08/03/1999US5932728 Antihistamines; antiallergens
08/03/1999US5932599 4-amino-n-(pyridinyl-4-yl)-benzenesulfonamides as active material treating malaria, bacterial infection, neurological disorders
08/03/1999US5932582 Fibrinogen receptor antagonist prodrugs
08/03/1999US5932580 PDGF receptor kinase inhibitory compounds their preparation and compositions
08/03/1999US5932577 Osteoporosis; antiarthritic agents; antiinflammatory agents;nervous system disorders; antitumor agents; cardiovascular disordersantitumor agentsd
08/03/1999US5932559 Treatment of hyperandrogenic conditions
07/1999
07/29/1999WO1999037618A1 Phenylalanine derivatives useful as pharmaceutical agents
07/29/1999WO1999037604A2 Dialkyl ureas as calcitonin mimetics
07/29/1999WO1999024537A3 O-substituted n,n-diacylhydroxylamine bleach activators and compositions employing the same
07/29/1999WO1999023587A3 Method of virtual retrieval of analogs of lead compounds
07/29/1999CA2284864A1 Dialkyl ureas as calcitonin mimetics
07/28/1999EP0931071A1 Methods of making hiv-protease inhibitors and intermediates for making them
07/28/1999EP0931065A2 Nitric ester derivatives and their use in urinary incontinence and other diseases
07/28/1999EP0931063A1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
07/28/1999EP0931060A1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
07/28/1999EP0931045A1 Matrix metalloproteinase inhibitors and their therapeutic uses
07/28/1999EP0918781A4 Asymmetric synthesis catalyzed by transition metal complexes with cyclic chiral ligands
07/28/1999EP0738258B1 Process for preparing n-substituted glycinic acids or glycine esters and use of said process in indigo synthesis
07/28/1999EP0604494B1 5-ht4 receptor antagonists
07/28/1999CN1224417A Fused isoindolones as inhibitors of protein kinase C
07/28/1999CN1224032A Use of isoindolinone derivatives as stabilizers for organic materials
07/28/1999CN1044366C Aryl-pyrrolidine-dione derivs., their preparing process and insecticidal and herbicidal agents contg. them and insecticidal and herbicidal use thereof
07/27/1999US5929265 Binuclear iridium(I) phosphine complexes and their use as catalyst in the asymmetric hydroamination of olefins
07/27/1999US5929217 Reactive dyes with a benzo-fused heterocycle as anchor
07/27/1999US5929120 Guainidino, formamidino, amino and related compounds for inhibiting osteoclast-mediated bone resorption
07/27/1999US5929110 Fatty acid analogs and prodrugs
07/27/1999US5929107 Inhibitors of acyl-coa:cholesterol acyltransferase
07/27/1999US5929067 N-acylating amine derivative of caprolactam compound with a carboxylic acid or derivatives to form amide derivative of caprolactam compound
07/27/1999US5929054 Use of NK-1 receptor antagonists for treating sexual dysfunctions
07/27/1999US5927283 Treating diseases involving oxygen deficiency, in wound healing, and in restoring oxygen affinity of stored blood.
07/27/1999CA2025663C Indole derivatives
07/27/1999CA1340680C Imide-aromatic peroxyacids as bleaching agents
07/27/1999CA1340679C Imide-aromatic peroxyacids
07/22/1999WO1999036422A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
07/22/1999WO1999036402A1 Process for preparing sparingly soluble aromatic amines
07/22/1999WO1999036401A1 Process for the preparation of 3-methyl-2-oxoindoline
07/22/1999WO1999036392A1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
07/22/1999WO1999036369A1 Use of a water soluble binder system for the production of glass or stone wool
07/22/1999WO1999036368A1 Compound for use as a mineral fibre binder and process for providing such
07/22/1999DE19751939A1 New aryl-substituted bi:cyclic heterocyclic compounds
07/22/1999CA2318418A1 Process for the preparation of 3-methyl-2-oxoindoline
07/22/1999CA2317439A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
07/21/1999EP0930297A1 A process for preparing naphthyridones and intermediates
07/21/1999EP0930292A1 PROCESS FOR PREPARING $g(b)-AMINO-$g(a)-HYDROXY ACID DERIVATIVES
07/21/1999EP0930067A2 Mmp inhibitors for the treatment of ocular angiogenesis
07/21/1999EP0929543A1 Herbicidal composition
07/21/1999EP0929542A1 Compounds for and a method of inhibiting matrix metalloproteinases
07/21/1999EP0929522A1 Insect-repellent formulations
07/21/1999EP0929521A1 Nmda (n-methyl-d-aspartate) antagonists
07/21/1999EP0929520A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease
07/21/1999EP0877767B1 Method of producing press-moulding materials with polyisocyanate binders and using latent, heat-activable catalysts
07/21/1999EP0765327B1 Pyrazolo and pyrrolopyridines
07/21/1999EP0750621B1 Heterocyclic compounds, their preparation and use
07/21/1999CN1223636A Matrix metalloproteinase inhibitors
07/21/1999CN1044249C Matrix metalloprotease inhibitors
07/21/1999CN1044244C 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT 1A-antagonistic activity
07/20/1999US5925770 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
07/20/1999US5925759 Producing nelfinavir mesylate from tartaric acid
07/20/1999US5925666 Dopamine uptake inhibitors; drug abuse and dependence, eating disorders, attention deficit disorder, tourette*s syndrome, gambling
07/20/1999CA2061143C Sulfonated xanthene filter dyes, and photographic products and processes employing these dyes
07/20/1999CA1340663C Preparation of 3-(3,4,5,6,-tetrahydrophthalimido)-benzaldehydes
07/20/1999CA1340657C Modulateurs de la proteine kinase c
07/15/1999WO1999035130A1 2,3-substituted indole compounds as cox-2 inhibitors
07/15/1999WO1999024026A3 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds
07/15/1999WO1999021848A3 Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
07/15/1999CA2316863A1 2,3-substituted indole compounds as cox-2 inhibitors